S&P 500
7,757.17
+44.60
+0.58%
Dow
52,856.09
+360.21
+0.69%
Nasdaq
26,702.86
+278.04
+1.05%
NYSE Composite
24,253.12
+62.51
+0.26%
Russell 2000
2,781.02
+7.60
+0.27%
VIX
16.68
-0.63
-3.64%
BEAM · Beam Therapeutics Inc.
NASDAQ NMS - GLOBAL MARKET - Real Time Price • USD
Beam Therapeutics Inc (BEAM)
NASDAQ NMS - GLOBAL MARKET
Biotechnology
$24.85
-0.08
(-0.32%)
● At close: October 21 at 4:00:00 PM EDT
$24.66
-0.18
(-0.72%)
After-Hours:
7:49:40 PM EDT
DAY'S RANGE
$24.85
$24.61
$25.19
52-WEEK RANGE
$24.85
$20.23
$38.26
What's happening
- BEAM is down 0.32% today, trading at $24.85. — Live quote
- Volume today (57,801) is well below its 3-month average of 2,053,240. (Finnhub fundamentals)
- Reports earnings on 2026-11-09, 19 days away. (Finnhub earnings calendar)
- Last quarter's EPS missed estimates: $-1.18 actual vs. $-1.13 estimated (-4.6%). (Finnhub earnings history)
Deterministic template sentences filled in from the same sourced figures shown elsewhere on this page -- not an AI-written summary, no live model call.
Key Statistics
Analyst Recommendations
Strong buy 8
Buy 11
Hold 3
Sell 0
Strong sell 0
Aggregate ratings for 2026-10-01 (22 analysts polled by Finnhub) — consensus count.
Performance Overview (Trailing returns vs S&P 500 benchmark)
YTD RETURN
BEAM
-10.06%
vs S&P 500
-22.84%
1-YEAR RETURN
BEAM
-18.58%
vs S&P 500
-33.14%
6-MONTH RETURN
BEAM
-17.80%
3-MONTH RETURN
BEAM
-8.65%
Earnings Trends (Quarterly EPS Actual vs Estimate)
2026-07-26 (Q2 2026)
$-1.18
Est. $-1.13
MISS -4.6%
2026-04-26 (Q1 2026)
$-0.91
Est. $-1.12
BEAT +18.6%
2026-01-26 (Q4 2025)
$-0.10
Est. $-1.01
BEAT +89.8%
2025-10-26 (Q3 2025)
$-1.10
Est. $-1.06
MISS -3.7%
Valuation Measures & Ratios
Enterprise Value4$2.46B
Forward P/E5—
PEG Ratio6—
Price / Sales (TTM1)16.54
Price / Book73.31
EV4 / Revenue15.77
EV4 / EBITDA—
Profit Margin-54.75%
Operating Margin-242.27%
Return on Equity (ROE8)-7.70%
Return on Assets (ROA9)-6.04%
Avg Volume (3M)2,053,240
Quarterly history (5 periods)
| Measure | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 |
|---|---|---|---|---|---|
| Market cap | $3.57B | $2.47B | $2.49B | $1.74B | $1.72B |
| P/E | -8.27 | -5.91 | -5.92 | -4.36 | -4.36 |
| Price/Sales | 70.84 | 43.02 | 62.28 | 41.40 | 42.06 |
| Price/Book | 3.34 | 2.12 | 2.57 | 1.65 | 1.52 |
| EV/Revenue | 68.46 | 39.74 | 55.56 | 34.68 | 29.15 |
| EV/EBITDA | -7.52 | -5.05 | -4.92 | — | — |
| ROE | -40.46% | -35.86% | -43.46% | -37.80% | -34.95% |
| ROA | -31.15% | -28.20% | -32.02% | -28.62% | -26.91% |
Trailing-twelve-month ratios computed from SEC EDGAR quarterly figures and historical daily close prices (Alpaca). Diluted shares are derived from Net income ÷ EPS (diluted) for each quarter, not separately reported. Forward P/E/PEG unavailable (no free data source).
Glossary — what these abbreviations mean
- 1. TTM
- Trailing twelve months — the sum of the last four reported quarters, not a calendar year or the single latest quarter.
- 2. EPS
- Earnings per share — net income divided by diluted shares outstanding.
- 3. Beta
- A stock's historical volatility relative to the overall market. Above 1 means it has moved more than the market; below 1, less.
- 4. EV (Enterprise Value)
- Market cap plus total debt minus cash — roughly what it would cost to buy the whole company, debt included.
- 5. Forward P/E
- Price divided by analysts' estimated earnings for the next 12 months, instead of trailing actual earnings.
- 6. PEG Ratio
- P/E divided by expected earnings growth rate. A lower number can indicate a stock is cheap relative to how fast it's expected to grow.
- 7. Price / Book
- Share price divided by book value (assets minus liabilities) per share.
- 8. ROE
- Return on equity — net income divided by shareholders' equity, a measure of how efficiently a company turns equity into profit.
- 9. ROA
- Return on assets — net income divided by total assets, a measure of how efficiently a company turns assets into profit.
- 10. MRQ
- Most recent quarter — the single latest reported period, as opposed to TTM. The Financials section's "Quarterly" view below shows MRQ-style figures.
- 11. YoY
- Year over year — percent change versus the same period one year earlier, used for growth figures like those on Compare cards and the Screener.
Short Interest
Shares Short27,548,815
Change from Prior Settlement+6.43%
% of Float—
Days to Cover (Short Ratio)15.30
Source: FINRA Rule 4560 consolidated short interest, settlement date 2026-09-30. Reported bi-monthly with a reporting lag — not real-time.
Quotes and the 1-day extended-hours chart: Yahoo Finance. Longer historical charts: Alpaca (IEX feed) — real-time but IEX-only volume (~2.5% of consolidated market volume). Fundamentals + earnings: Finnhub.
Price history
Events
Drag horizontally to zoom into a section; use Reset view to restore all observations.
Technical signal summary
Calculating from the latest year of daily price history…
Show Technical Analysis Breakdown ▾ 10 Indicators
Not investment advice — read several signals together.
Indicators None active
Loading chart…
History limited by data provider; markers are heuristics, not signals.
Peer and sector context
No reviewed peer group is available for this symbol.
Balanced evidence
A deterministic summary of sourced facts—not an AI verdict.
Potential strengths
- Latest SEC filing is Form 4, filed 2026-10-16; review it for current changes and risks. SEC EDGAR ↗
Potential concerns
- Revenue growth is -94.2% on the provider's reported measure. Finnhub fundamentals ↗
- Net profit margin is -54.8%. Finnhub fundamentals ↗
- Trailing 52-week price return is -18.6%. Finnhub market metrics ↗
Rule-based facts only; absence from either side is not evidence, and this is not a recommendation.
More on BEAM
No accessible free API for these — links go to the source directly.
Financials
Fundamental trends
Visualized from the same SEC figures in the tables below.
Income statement
| Line item | Jun '26 | Mar '26 | Sep '25 | Jun '25 | Mar '25 | Sep '24 | Jun '24 | Mar '24 |
|---|---|---|---|---|---|---|---|---|
| Revenue | $490.0K | $31.7M | $9.7M | $8.5M | $7.5M | $14.3M | $11.8M | $7.4M |
| Operating income | -$126.6M | -$107.2M | -$126.8M | -$120.2M | -$119.3M | -$106.5M | -$104.9M | -$104.1M |
| Net income | -$122.7M | -$94.3M | -$112.7M | -$102.1M | -$108.3M | -$96.7M | -$91.1M | -$98.7M |
| EPS (diluted) | $-1.18 | $-0.91 | $-1.10 | $-1.00 | $-1.23 | $-1.17 | $-1.11 | $-1.21 |
| EPS (basic) | $-1.18 | $-0.91 | $-1.10 | $-1.00 | $-1.23 | $-1.17 | $-1.11 | $-1.21 |
| Operating margin | -$25.8K | -$338 | -$1.3K | -$1.4K | -$1.6K | -$746 | -$891 | -$1.4K |
| Net margin | -$25.0K | -$297 | -$1.2K | -$1.2K | -$1.5K | -$677 | -$773 | -$1.3K |
Balance sheet
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Total assets | $1.39B | $1.48B | $1.48B | $1.31B | $1.39B | $1.47B | $1.10B | $1.17B |
| Total liabilities | $318.9M | $316.4M | $242.8M | $345.1M | $344.3M | $343.8M | $370.3M | $380.1M |
| Stockholders' equity | $1.07B | $1.16B | $1.24B | $966.0M | $1.05B | $1.13B | $733.5M | $791.3M |
| Total current assets | $1.18B | $1.27B | $1.27B | $1.10B | $1.18B | $1.25B | $878.1M | $945.5M |
| Total current liabilities | $80.9M | $74.6M | $96.9M | $182.6M | $174.1M | $141.5M | $182.1M | $166.2M |
| Cash & equivalents | $219.8M | $288.3M | $294.9M | $268.0M | $282.1M | $527.9M | $282.0M | $230.2M |
| Marketable securities (current) | $933.1M | $923.4M | $950.3M | $807.0M | $868.2M | $692.0M | $568.8M | $695.6M |
| Marketable securities (non-current) | — | — | — | — | — | — | — | — |
| Property, plant & equipment | $97.6M | $101.2M | $104.5M | $108.3M | $108.8M | $109.6M | $111.4M | $113.5M |
| Other non-current assets | $7.9M | $7.8M | $634.0K | $593.0K | $668.0K | $911.0K | $1.3M | $1.1M |
| Accounts payable | $13.1M | $12.3M | $10.2M | $9.5M | $10.6M | $7.7M | $3.9M | $3.8M |
| Deferred revenue (current) | $0 | $304.0K | $6.7M | $110.3M | $105.8M | $85.2M | $108.9M | $89.3M |
| Long-term debt | $100.3M | $100.2M | — | — | — | — | — | — |
| Other non-current liabilities | $293.0K | $305.0K | $173.0K | $266.0K | $357.0K | $414.0K | $504.0K | $481.0K |
| Common stock & paid-in capital | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $1.0M | $836.0K | $826.0K |
| Retained earnings | -$1.86B | -$1.74B | -$1.64B | -$1.89B | -$1.78B | -$1.68B | -$1.57B | -$1.48B |
| Accumulated other comprehensive income (loss) | -$2.2M | -$1.1M | $1.1M | $790.0K | $10.0K | $160.0K | $679.0K | $1.8M |
Cash flow
| Line item | Jun '26 | Mar '26 | Dec '25 | Sep '25 | Jun '25 | Mar '25 | Dec '24 | Sep '24 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | -$66.1M | -$128.5M | -$83.3M | -$81.5M | -$76.5M | -$103.9M | -$76.4M | -$88.1M |
| Investing cash flow | -$9.9M | $25.3M | $108.4M | $65.7M | -$170.4M | -$125.1M | $126.3M | $24.7M |
| Financing cash flow | $7.5M | $96.6M | $1.9M | $1.7M | $1.1M | $473.4M | $3.4M | $1.3M |
| Free cash flow | -$68.5M | -$130.7M | -$87.0M | -$86.5M | -$79.6M | -$106.9M | -$79.3M | -$89.7M |
| Capital expenditures | $2.4M | $2.2M | $3.7M | $5.0M | $3.1M | $3.1M | $3.0M | $1.6M |
| Depreciation & amortization | $5.4M | $5.6M | $5.7M | $5.6M | $5.5M | $5.5M | $5.4M | $5.5M |
| Share-based compensation | $19.3M | $19.0M | $20.4M | $22.7M | $24.4M | $26.7M | $30.2M | $29.6M |
| Change in accounts payable | $1.2M | $2.2M | $1.2M | -$1.6M | $2.6M | $3.8M | -$550.0K | -$700.0K |
| Purchases of investments | $180.9M | $153.8M | $361.0M | $175.6M | $333.9M | $339.2M | $0 | $156.7M |
| Sales/maturities of investments | $173.0M | $181.3M | $218.0M | $240.6M | $166.7M | $217.1M | $129.2M | $183.0M |
Income statement
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Revenue | $139.7M | $63.5M | $377.7M | $60.9M | $51.8M |
| Operating income | -$383.7M | -$415.6M | -$176.5M | -$338.5M | -$392.5M |
| Net income | -$80.0M | -$376.7M | -$132.5M | -$289.1M | -$370.6M |
| EPS (diluted) | $-0.81 | $-4.58 | $-1.72 | $-4.13 | $-5.77 |
| EPS (basic) | $-0.81 | $-4.58 | $-1.72 | $-4.13 | $-5.77 |
| Operating margin | -$275 | -$654 | -$47 | -$556 | -$757 |
| Net margin | -$57 | -$593 | -$35 | -$475 | -$715 |
Balance sheet
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Total assets | $1.48B | $1.10B | $1.46B | $1.34B | $1.47B |
| Total liabilities | $242.8M | $370.3M | $478.4M | $608.2M | $647.7M |
| Stockholders' equity | $1.24B | $733.5M | $981.3M | $733.5M | $826.7M |
| Total current assets | $1.27B | $878.1M | $1.21B | $1.09B | $1.27B |
| Total current liabilities | $96.9M | $182.1M | $205.6M | $223.6M | $213.4M |
| Cash & equivalents | $294.9M | $282.0M | $435.9M | $232.8M | $560.0M |
| Marketable securities (current) | $950.3M | $568.8M | — | — | — |
| Property, plant & equipment | $104.5M | $111.4M | $125.0M | $115.6M | $84.3M |
| Other non-current assets | $634.0K | $1.3M | $2.1M | $1.9M | $1.7M |
| Accounts payable | $10.2M | $3.9M | $1.6M | $9.0M | $7.5M |
| Deferred revenue (current) | $6.7M | $108.9M | $68.7M | $136.0M | $86.3M |
| Other non-current liabilities | $173.0K | $504.0K | $298.0K | $1.4M | $2.8M |
| Common stock & paid-in capital | $1.0M | $836.0K | $816.0K | $712.0K | $684.0K |
| Retained earnings | -$1.64B | -$1.57B | -$1.19B | -$1.06B | -$768.3M |
| Accumulated other comprehensive income (loss) | $1.1M | $679.0K | $604.0K | -$2.4M | -$50.0K |
Cash flow
| Line item | Dec '25 | Dec '24 | Dec '23 | Dec '22 | Dec '21 |
|---|---|---|---|---|---|
| Operating cash flow | -$345.1M | -$347.2M | -$149.2M | $22.5M | -$66.3M |
| Investing cash flow | -$121.4M | $185.0M | $71.8M | -$461.3M | -$294.1M |
| Financing cash flow | $478.0M | $7.7M | $276.4M | $111.6M | $756.1M |
| Free cash flow | -$360.0M | -$356.2M | -$182.9M | -$26.4M | -$113.1M |
| Capital expenditures | $14.9M | $8.9M | $33.7M | $49.0M | $46.8M |
| Depreciation & amortization | $22.3M | $21.9M | $20.0M | $14.1M | $7.5M |
| Share-based compensation | $94.2M | $120.7M | $98.6M | $84.3M | $43.6M |
| Change in accounts payable | $6.0M | $1.8M | -$7.6M | $2.4M | $818.0K |
| Purchases of investments | $1.21B | $486.4M | $984.3M | $1.62B | $777.2M |
| Sales/maturities of investments | $842.5M | $680.4M | $1.09B | $1.20B | $529.3M |
Source: SEC EDGAR XBRL filings (10-Q/10-K), as originally tagged by the company. Quarterly cash flow is reconstructed by de-cumulating fiscal-year-to-date figures (how cash flow is tagged in 10-Qs); other quarterly lines are reported directly.
Institutional holders
SEC Form 13F filers holding BEAM as of the latest reported quarter. 13F only covers investment managers with $100M+ in assets — this is not a complete ownership picture, and does not include insiders (see Recent SEC filings below) or non-13F-eligible holders.
Source: Business Quant SEC Form 13F · report period 2026-06-30 · 32 filers
Held by These Filers94.5%
Shares Outstanding104,326,669
| Filer | Shares | Value | % Out | Qtr Change | Filed |
|---|---|---|---|---|---|
| FMR LLC | 12,609,002 | $432.7M | 12.09% | +1.3% | 2026-08-13 |
| FARALLON CAPITAL MANAGEMENT, L.L.C. | 10,236,396 | $351.3M | 9.81% | +1.0% | 2026-08-14 |
| ARK Investment Management LLC | 10,234,862 | $351.3M | 9.81% | -15.6% | 2026-08-14 |
| BlackRock, Inc. | 8,997,542 | $308.8M | 8.62% | +6.0% | 2026-08-07 |
| State Street Corp | 5,827,122 | $200.0M | 5.59% | +2.2% | 2026-08-07 |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 4,921,259 | $168.9M | 4.72% | +7.7% | 2026-06-30 |
| VANGUARD CAPITAL MANAGEMENT LLC | 4,599,437 | $157.9M | 4.41% | +5.1% | 2026-06-30 |
| ARCH Venture Management, LLC | 4,540,132 | $155.8M | 4.35% | +0.0% | 2026-08-14 |
| Amova Asset Management Americas, Inc. | 3,455,043 | $118.5M | 3.31% | -9.7% | 2026-08-13 |
| Sumitomo Mitsui Trust Group, Inc. | 3,455,043 | $118.6M | 3.31% | -9.7% | 2026-07-30 |
| PRICE T ROWE ASSOCIATES INC /MD/ | 3,415,239 | $117.2K | 3.27% | +25.9% | 2026-08-14 |
| Kynam Capital Management, LP | 2,840,792 | $97.5M | 2.72% | -22.9% | 2026-08-14 |
| GEODE CAPITAL MANAGEMENT, LLC | 2,596,963 | $89.1M | 2.49% | +7.4% | 2026-08-12 |
| DIMENSIONAL FUND ADVISORS LP | 2,225,844 | $76.4M | 2.13% | +3.3% | 2026-08-11 |
| Morgan Stanley | 1,950,969 | $67.0M | 1.87% | +201.0% | 2026-08-11 |
| Contrarius Group Holdings Ltd | 1,614,538 | $55.4M | 1.55% | +202.7% | 2026-08-11 |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC | 1,551,781 | $53.3M | 1.49% | -6.2% | 2026-08-13 |
| TWO SIGMA INVESTMENTS, LP | 1,388,227 | $47.6M | 1.33% | +14.6% | 2026-08-07 |
| Casdin Capital, LLC | 1,350,000 | $46.3M | 1.29% | +0.0% | 2026-08-14 |
| Goldman Sachs Group Inc | 1,310,059 | $45.0M | 1.26% | +30.3% | 2026-08-14 |
| Redmile Group, LLC | 1,164,259 | $40.0M | 1.12% | -5.9% | 2026-08-14 |
| BNP PARIBAS FINANCIAL MARKETS | 1,067,883 | $36.6M | 1.02% | +52.4% | 2026-08-10 |
| Deep Track Capital, LP | 1,000,000 | $34.3M | 0.96% | +21.8% | 2026-08-14 |
| Northern Trust Corp | 933,481 | $32.0M | 0.89% | +13.1% | 2026-08-12 |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC | 885,902 | $30.4M | 0.85% | +9.6% | 2026-08-14 |
Insider activity
Directors, officers, and 10%+ owners' reported transactions from SEC Form 4. A filing reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR Form 4 filings · checked 25 most recent filings · covers 2026-03-30 to 2026-10-16
Recent transactions
- Insiders have net sold 402,087 shares over the last 182 days, across 0 purchases and 11 sales.
- Most recent: Evans John M. (CEO) — Option exercise of 25,000 shares on 2026-10-16.
Deterministic template sentences filled in from the SEC Form 4 figures in the tables below -- not an AI-written summary, no live model call.
Insider purchases & sales, last 6 months
Purchases (open market)0 sh(0 txns)
Sales (open market)402,087 sh(11 txns)
Net Shares-402,087
Counts only open-market purchases (code P) and sales (code S) — grants, option exercises, tax withholding, and gifts are excluded since they aren't a market buy/sell decision.
Insider roster
| Name | Title | Most Recent Transaction | Date | Shares |
|---|---|---|---|---|
| Evans John M. | CEO | Option exercise | 2026-10-16 | 25,000 |
| Cavanagh Bethany J | SVP, Finance and Treasurer | Open market sale | 2026-10-01 | 187 |
| Ciaramella Giuseppe | President | Gift | 2026-09-24 | 123,407 |
| Simon Amy | Chief Medical Officer | Open market sale | 2026-07-27 | 16,667 |
| FMR LLC | Reporting person | Open market sale | 2026-06-26 | 251,488 |
| Bellon Christine | Chief Legal Officer | Open market sale | 2026-04-01 | 5,956 |
| Emany Sravan Kumar | Chief Financial Officer | Grant / award | 2026-03-31 | 31,750 |
Recent transactions
| Date | Insider | Title | Transaction | Shares | Price |
|---|---|---|---|---|---|
| 2026-10-16 | Evans John M. | CEO | Option exercise | 25,000 | $1.03 |
| 2026-10-16 | Evans John M. | CEO | Open market sale | 25,000 | $23.98 |
| 2026-10-15 | Evans John M. | CEO | Option exercise | 25,000 | $1.03 |
| 2026-10-15 | Evans John M. | CEO | Open market sale | 25,000 | $23.57 |
| 2026-10-01 | Cavanagh Bethany J | SVP, Finance and Treasurer | Open market sale | 187 | $24.41 |
| 2026-09-24 | Ciaramella Giuseppe | President | Gift | 123,407 | $0.00 |
| 2026-07-27 | Simon Amy | Chief Medical Officer | Open market sale | 16,667 | $25.74 |
| 2026-06-30 | Simon Amy | Chief Medical Officer | Open market sale | 373 | $34.73 |
| 2026-06-30 | Evans John M. | CEO | Option exercise | 25,000 | $1.03 |
| 2026-06-30 | Evans John M. | CEO | Open market sale | 23,100 | $34.26 |
| 2026-06-30 | Evans John M. | CEO | Open market sale | 1,900 | $34.84 |
| 2026-06-29 | Evans John M. | CEO | Option exercise | 18,663 | $0.67 |
| 2026-06-29 | Evans John M. | CEO | Option exercise | 6,337 | $1.03 |
| 2026-06-29 | Evans John M. | CEO | Open market sale | 13,421 | $35.13 |
| 2026-06-29 | Evans John M. | CEO | Open market sale | 11,579 | $35.91 |
| 2026-06-26 | FMR LLC | Reporting person | Open market sale | 251,488 | $35.26 |
| 2026-06-25 | FMR LLC | Reporting person | Open market sale | 33,372 | $35.12 |
| 2026-06-17 | Ciaramella Giuseppe | President | Option exercise | 6,505 | $0.67 |
| 2026-06-17 | Ciaramella Giuseppe | President | Option exercise | 29,000 | $1.03 |
| 2026-04-01 | Evans John M. | CEO | Open market sale | 30,078 | $24.58 |
| 2026-04-01 | Simon Amy | Chief Medical Officer | Open market sale | 6,700 | $24.58 |
| 2026-04-01 | Cavanagh Bethany J | SVP, Finance and Treasurer | Open market sale | 3,242 | $24.58 |
| 2026-04-01 | Bellon Christine | Chief Legal Officer | Open market sale | 5,956 | $24.58 |
| 2026-04-01 | Ciaramella Giuseppe | President | Open market sale | 11,810 | $24.58 |
| 2026-03-31 | Bellon Christine | Chief Legal Officer | Grant / award | 20,000 | $0.00 |
| 2026-03-31 | Cavanagh Bethany J | SVP, Finance and Treasurer | Grant / award | 20,000 | $0.00 |
| 2026-03-31 | Simon Amy | Chief Medical Officer | Grant / award | 31,750 | $0.00 |
| 2026-03-31 | Emany Sravan Kumar | Chief Financial Officer | Grant / award | 31,750 | $0.00 |
| 2026-03-31 | Ciaramella Giuseppe | President | Grant / award | 40,000 | $0.00 |
| 2026-03-31 | Evans John M. | CEO | Option exercise | 25,000 | $0.67 |
| 2026-03-31 | Evans John M. | CEO | Open market sale | 25,000 | $22.76 |
| 2026-03-31 | Evans John M. | CEO | Grant / award | 90,000 | $0.00 |
| 2026-03-30 | Evans John M. | CEO | Option exercise | 25,000 | $0.67 |
| 2026-03-30 | Evans John M. | CEO | Open market sale | 25,000 | $22.37 |
Recent SEC filings
Official company reports and insider transaction filings. Form 4 reports a transaction; it does not by itself explain why it happened.
Source: SEC EDGAR submissions · updated 2026-10-21 23:52 UTC
| Filed | Form | Report period | Official filing |
|---|---|---|---|
| 2026-10-16 | 4 | 2026-10-15 | View on SEC.gov → |
| 2026-10-02 | 4 | 2026-10-01 | View on SEC.gov → |
| 2026-09-25 | 4 | 2026-09-24 | View on SEC.gov → |
| 2026-08-04 | 10-Q | 2026-06-30 | View on SEC.gov → |
| 2026-08-04 | 8-K | 2026-08-04 | View on SEC.gov → |
| 2026-07-29 | 4 | 2026-07-27 | View on SEC.gov → |
| 2026-07-02 | 4 | 2026-06-30 | View on SEC.gov → |
| 2026-07-01 | 4 | 2026-06-29 | View on SEC.gov → |
| 2026-06-29 | 4 | 2026-06-25 | View on SEC.gov → |
| 2026-06-22 | 4 | 2026-06-17 | View on SEC.gov → |
| 2026-06-08 | 8-K | 2026-06-03 | View on SEC.gov → |
| 2026-06-05 | 4 | 2026-06-03 | View on SEC.gov → |
Recent news
Headlines about BEAM (Beam Therapeutics Inc.). Links open the publisher — we don’t host full articles.
-
Beam Global deploys EV charging systems to California tribes By Investing.com
Investing.com Nigeria · 2026-10-21 -
Beam Global Deploys Off-Grid EV ARC Charging Systems for California Tribal Communities
Quiver Quantitative · 2026-10-21 -
(BEAM) Movement as an Input in Quant Signal Sets
Stock Traders Daily · 2026-10-21 -
Does Ark Buying More Shares Change The Bull Case For Beam Therapeutics (BEAM)?
Simply Wall Street · 2026-10-20 -
Lane closures planned on I-71 South in Louisville for bridge beam work
WHAS11 · 2026-10-19 -
3M to Invest in GSEO as Part of Expanded Beam Optical Collaboration
IndexBox · 2026-10-19 -
3M announces collaboration with GSEO to advance Expanded Beam Optical manufacturing and development
Yahoo Finance · 2026-10-19 -
Beam Global (BEEM) Stock Price Prediction for 2026, 2030-2040
Traders Union · 2026-10-19
No headlines in this category right now — try “All”.